O'Donnell JS - Search Results

1

O-glycan determinants regulate VWF trafficking to Weibel-Palade bodies.

Karampini E, Doherty D, Bürgisser PE, Garre M, Schoen I, Elliott S, Bierings R, O'Donnell JS. Karampini E, et al. Blood Adv. 2024 Jun 25;8(12):3254-3266. doi: 10.1182/bloodadvances.2023012499. Blood Adv. 2024. PMID: 38640438 Free PMC article.

2

Elucidating the role of carbohydrate determinants in regulating hemostasis: insights and opportunities.

Preston RJ, Rawley O, Gleeson EM, O'Donnell JS. Preston RJ, et al. Blood. 2013 May 9;121(19):3801-10. doi: 10.1182/blood-2012-10-415000. Epub 2013 Feb 20. Blood. 2013. PMID: 23426946 Free article. Review.

3

Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis.

McGrath RT, van den Biggelaar M, Byrne B, O'Sullivan JM, Rawley O, O'Kennedy R, Voorberg J, Preston RJ, O'Donnell JS. McGrath RT, et al. Blood. 2013 Dec 12;122(25):4107-10. doi: 10.1182/blood-2013-04-496851. Epub 2013 Oct 8. Blood. 2013. PMID: 24106205 Free article.

4

N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance.

Chion A, O'Sullivan JM, Drakeford C, Bergsson G, Dalton N, Aguila S, Ward S, Fallon PG, Brophy TM, Preston RJ, Brady L, Sheils O, Laffan M, McKinnon TA, O'Donnell JS. Chion A, et al. Blood. 2016 Oct 13;128(15):1959-1968. doi: 10.1182/blood-2016-04-709436. Epub 2016 Aug 23. Blood. 2016. PMID: 27554083 Free article.

5

Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels.

Lavin M, Aguila S, Schneppenheim S, Dalton N, Jones KL, O'Sullivan JM, O'Connell NM, Ryan K, White B, Byrne M, Rafferty M, Doyle MM, Nolan M, Preston RJS, Budde U, James P, Di Paola J, O'Donnell JS. Lavin M, et al. Blood. 2017 Nov 23;130(21):2344-2353. doi: 10.1182/blood-2017-05-786699. Epub 2017 Sep 15. Blood. 2017. PMID: 28916584 Free PMC article. Clinical Trial.

6

A novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance.

Ward SE, O'Sullivan JM, Drakeford C, Aguila S, Jondle CN, Sharma J, Fallon PG, Brophy TM, Preston RJS, Smyth P, Sheils O, Chion A, O'Donnell JS. Ward SE, et al. Blood. 2018 Feb 22;131(8):911-916. doi: 10.1182/blood-2017-06-787853. Epub 2017 Dec 27. Blood. 2018. PMID: 29282218 Free article.

7

Significant gynecological bleeding in women with low von Willebrand factor levels.

Lavin M, Aguila S, Dalton N, Nolan M, Byrne M, Ryan K, White B, O'Connell NM, O'Sullivan JM, Di Paola J, James PD, O'Donnell JS. Lavin M, et al. Blood Adv. 2018 Jul 24;2(14):1784-1791. doi: 10.1182/bloodadvances.2018017418. Blood Adv. 2018. PMID: 30042144 Free PMC article. Clinical Trial.

8

Missed at first Glanz: Glanzmann thrombasthenia initially misdiagnosed as Von Willebrand Disease.

Doherty D, Singleton E, Byrne M, Ryan K, O'Connell NM, O'Donnell JS, Lavin M. Doherty D, et al. Transfus Apher Sci. 2019 Feb;58(1):58-60. doi: 10.1016/j.transci.2018.11.008. Epub 2018 Dec 5. Transfus Apher Sci. 2019. PMID: 30551951

9

How I treat low von Willebrand factor levels.

Lavin M, O'Donnell JS. Lavin M, et al. Blood. 2019 Feb 21;133(8):795-804. doi: 10.1182/blood-2018-10-844936. Epub 2018 Dec 21. Blood. 2019. PMID: 30578256 Free article. Review.

10

Blood group alters platelet binding kinetics to von Willebrand factor and consequently platelet function.

Dunne E, Qi QM, Shaqfeh ES, O'Sullivan JM, Schoen I, Ricco AJ, O'Donnell JS, Kenny D. Dunne E, et al. Blood. 2019 Mar 21;133(12):1371-1377. doi: 10.1182/blood-2018-06-855528. Epub 2019 Jan 14. Blood. 2019. PMID: 30642918 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters